Sharechat Logo

Govt tips further $60M into venture fund to encourage private investors

Wednesday 27th February 2013

Text too small?

The government is backing the New Zealand Venture Investment Fund with a further $60 million as part of its efforts to encourage more private investment.

The latest injection follows a previous $40 million underwrite and is on top of the $160 million the government has already allocated to the venture capital programme.

"The underwrite facility is a contingent liability rather than an upfront sum," said Economic Development Minister Steven Joyce. "It provides the flexibility so that NZVIF can continue to make commitments into new venture capital funds and then use future cash flows from existing investments to meet those commitments."

NZVIF was set up by the government in 2002 as a private equity fund of funds investor, with about $200 million under management, made up of the $160 million Venture Capital Fund of Funds and the $40 million Seed Co-investment Fund.

So far it has invested $117 million in 126 companies which have gone on to raise total investment capital of $700 million, generated revenue of $1.25 billion and export earnings of $945 million. Notables include Orion Health, SLI Systems, PowerbyProxi, Booktrack, BioVittoria and Zephyr Technology.

"Capital markets are the growth engine for the economy but some parts can be strengthened," Joyce said.

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors